Arcus Biosciences RCUS Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Arcus Biosciences’s reported figures.
Plus components not separately reported this period.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's total debt?
- Arcus Biosciences (RCUS) reported total debt of $113M in Q1 2026.
- How has Arcus Biosciences's total debt changed year-over-year?
- Arcus Biosciences's total debt increased by 88.3% year-over-year, from $60M to $113M.
- What is the long-term trend for Arcus Biosciences's total debt?
- Over 5 years (2020 to 2025), Arcus Biosciences's total debt has grown at a 61.3% compound annual growth rate (CAGR), from $18.11M to $198M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.